Identification of a Functional Type VI Secretion System in Campylobacter jejuni Conferring Capsule Polysaccharide Sensitive Cytotoxicity

Abstract

The pathogen Campylobacter jejuni is the principal cause of bacterial food-borne infections. The mechanism(s) that contribute to bacterial survival and disease are still poorly understood. In other bacterial species, type VI secretion systems (T6SS) are increasingly recognized to contribute to bacterial pathogenesis by toxic effects on host cells or competing bacterial species. Here we report the presence of a functional Type VI secretion system in C. jejuni. Proteome and genetic analyses revealed that C. jejuni strain 108 contains a 17-kb T6SS gene cluster consisting of 13 T6SS-conserved genes, including the T6SS hallmark genes hcp and vgrG. The cluster lacks an ortholog of the ClpV ATPase considered important for T6SS function. The sequence and organization of the C. jejuni T6SS genes resemble those of the T6SS located on the HHGI1 pathogenicity island of Helicobacter hepaticus. The C. jejuni T6SS is integrated into the earlier acquired Campylobacter integrated element CJIE3 and is present in about 10% of C. jejuni isolates including several isolates derived from patients with the rare clinical feature of C. jejuni bacteremia. Targeted mutagenesis of C. jejuni T6SS genes revealed T6SS-dependent secretion of the Hcp needle protein into the culture supernatant. Infection assays provided evidence that the C. jejuni T6SS confers contact-dependent cytotoxicity towards red blood cells but not macrophages. This trait was observed only in a capsule-deficient bacterial phenotype. The unique C. jejuni T6SS phenotype of capsule-sensitive contact-mediated hemolysis represents a novel evolutionary pathway of T6SS in bacteria and expands the repertoire of virulence properties associated with T6SS.

Author Summary

Bacteria contain a number of secretion systems to export macromolecules to the environment. The bacterial type VI secretion system (T6SS) forms a needle-like structure that delivers toxic effector molecules to neighboring eukaryotic and/or prokaryotic cells. Here we report that the important human pathogen Campylobacter jejuni contains a functional T6SS gene cluster. The cluster comprises 13 conserved T6SS genes including genes encoding the typical T6SS Hcp and VgrG proteins. The gene cluster is part of a larger DNA element and is present in about 10% of C. jejuni strains including several blood isolates. The identified C. jejuni T6SS has unique properties compared to similar systems in other bacterial species. C. jejuni T6SS lacks the ClpV ATPase that supposedly energizes part of T6SS function in other species, causes contact-dependent lysis of red blood cells, and requires downregulation of the C. jejuni capsule polysaccharide to be effective. The unique cytotoxic properties of C. jejuni T6SS, the effect of the capsule on T6SS function, and the possible association with systemic C. jejuni infection broaden the scope of the existing bacterial T6SS phenotypes and point to a different evolution of C. jejuni T6SS compared to other bacterial species.

Introduction

Gram-negative bacteria have evolved at least six types of protein secretion systems (type I–VI) to export proteins to the periplasmic space or the environment [1]. Several secretion systems are composed of needle-like structures that span the bacterial cell wall and protrude from the cell surface. These nanomachines include the classical type III and type IV secretion apparatus involved the injection of bacterial proteins into eukaryotic cells. One more recently discovered bacterial needle structure is the type VI secretion system (T6SS) as originally described for Vibrio cholerae and Pseudomonas aeruginosa [2], [3]. Today whole genome analyses have predicted T6SS gene clusters to be present in more than 100 Gram-negative bacterial species. These gene clusters often have of a variable composition but typically contain at least 13 core genes that encode the basic elements of the injection apparatus [4]–[6].

Structurally the T6SS consists of a membrane-associated assembly platform and a needle structure that transports effector molecules into neighboring bacteria or eukaryotic cells. A number of the T6SS core proteins show similarity to elements of tailed bacteriophages. Examples are the baseplate gp-25-like protein VCA109, the tail sheath-like proteins TssB and TssC (VipA/VipB), the tail subunit-like hemolysin co-regulated protein (Hcp) that polymerizes into the T6SS needle structure, and the valine-glycine repeat protein (VgrG) that forms the spike of the nanotube [4]–[6]. The structural similarity with bacteriophage proteins has led to the hypothesis that T6SS resemble an inverted bacteriophage tail structure that is exposed at the surface of the bacterial cell wall [7], [8]. Recently, contraction and extension of the VipA/B tubular sheath of the T6SS of V. cholerae have been visualized in vivo, supporting the model that the T6SS sheath is a dynamic contractile structure that projects the T6SS spike into the target cell analogous to bacteriophage entry [9], [10]. Disassembly of the contracted sheath requires the T6SS ClpV ATPase [9], [11], [12]. Another group of T6SS building blocks (TssM-L) seems related to proteins of the type IV secretion system (i.e. IcmF and IcmH/DotU) [13], [14]. These proteins may be involved in the recruitment of Hcp to the T6SS inner membrane assembly platform [15].

The hallmark of a functional T6SS is the presence of Hcp and VgrG in the culture supernatant [3], [16]–[18]. Both proteins may exert effector functions on eukaryotic cells [16], [19]–[21]. For the VgrG protein this function is often associated with the presence of an additional C-terminal effector module. Once in contact with eukaryotic cells, the extended C-terminal domain induces cross-linking or ADP-ribosylation of actin in eukaryotic cells, promoting intestinal inflammation and host cell toxicity [16], [19], [21]. Other identified T6SS effector molecules include the VasX protein secreted by V. cholerae that binds membrane lipids [22] and toxic proteins that target prokaryotes to provide a competitive advantage against other microorganisms occupying the same niche. Examples are the Tse2 toxin and the Tse1 and Tse3 proteins with peptidoglycan hydrolyzing activity in Pseudomonas aeruginosa [23]–[25]. These toxins may be representatives of a widespread T6SS effector superfamily with antibacterial properties [26].

Campylobacter jejuni is one of the principal bacterial food-borne pathogens causing millions of cases of gastroenteritis worldwide. Yet, the pathogenesis of C. jejuni infections is still poorly understood and a limited number of potential virulence determinants have been identified [27]. In the present study we report the identification of a functional T6SS in C. jejuni. The T6SS gene cluster is part of an integration element present in the genomes of a subset of C. jejuni strains. The system shows several unique traits compared to other bacterial T6SS including contact-dependent lysis of red blood cells and capsule expression-sensitive T6SS function.

Results

Identification of a C. jejuni Hcp ortholog

Proteome analysis of whole bacterial lysates of C. jejuni strain 108 using two-dimensional gel electrophoresis and liquid chromatography mass-spectrometry (LC-MS) revealed a ∼20 kDa protein that contained 4 peptide sequences most similar to a Campyobacter coli protein annotated in the NCBI database either as hypothetical protein or as putative hemolysin co-regulated protein (Hcp) (Fig. 1). We amplified the putative C. jejuni hcp gene from strain 108 by PCR with primers designed on the basis of the C. coli hcp sequence. Cloning and sequence analysis of the PCR product indicated that the C. jejuni gene encodes one open reading frame of 171 amino acids and contains the DUF796 domain which is conserved among Hcp proteins. The C. jejuni Hcp shows 76% similarity to the V. cholerae Hcp protein [28] and 69% similarity to the well characterized Hcp protein of Pseudomonas aeruginosa [2], [29].

Figure 1. Two-dimensional SDS-PAGE of isolated whole bacterial lysate derived from C. jejuni strain 108.

Proteins were visualized with silver. The encircled protein spot was picked and identified by mass spectrometry as a putative C. jejuni Hcp protein.

C. jejuni strain 108 contains a T6SS gene cluster

In search for evidence of the presence of a complete T6SS gene cluster in C. jejuni strain 108, we determined the flanking regions of the hcp gene by primer walking. This strategy yielded a putative C. jejuni T6SS gene cluster of ∼17 kilobases consisting of 13 open reading frames with tight intergenic spacing (less than 30 bp) (Fig. 2A). The genes seemed organized in several groups based on gene orientation and were designated as C. jejuni tssA-M following the proposed nomenclature for T6SS components [5], [30]. The organization of the T6SS genes of C. jejuni strain 108 resembled but was not identical to the organization of the cluster in C. coli and Helicobacter hepaticus (Fig. 2B).

Figure 2. Gene organization of the T6SS clusters in C. jejuni strain 108 and related species.

(A) The C. jejuni genes are designated according to the proposed nomenclature [5], [29] as ttsA-M; alternative gene names in V. cholerae are given in brackets for comparison. Functionally related group of genes are indicated in the same color. The lines and numbers below the colored genes indicate the PCR products and primers used for cloning and sequencing by primer walking. The same PCR primer sets were used to determine the gene organization in other Hcp-positive C. jejuni strains. (B) Comparison of the T6SS gene cluster organizations in C. jejuni strain 108, C. coli strain RM2228, H. hepaticus strain ATCC51449 and V. cholerae strain V52. Functionally related group of genes are indicated in the same color. (C) Diagram indicating the site of insertion of the C. jejuni 108 T6SS gene cluster relative to the CJIE3 element of C. jejuni RM1221.

Closer inspection revealed that in the first group of genes the C. jejuni hcp gene (tssD) of strain 108 is located in reverse orientation between the tssJ-M genes (Fig. 2A). The products of these genes show 46–55% similarity with TssJ-TssM proteins which in several other species form essential components of the membrane platform of the T6SS secretion apparatus [13], [31]. C. jejuni TssJ (17 kDa) has a putative lipoprotein signal peptidase cleavage site (LFFCA/CSSVV) and a serine residue at position +2 which may sort the protein to the outer membrane [13], [32]. C. jejuni TssK (53 kDa) lacks an apparent signal sequence and resembles a conserved T6SS protein with unknown function. The putative C. jejuni TssL (30 kDa) and TssM (137 kDa) proteins are predicted to have transmembrane domains and coiled-coil structures. Both proteins share characteristics with the IcmH/DotU and IcmF proteins originally identified as non-essential components of a type IV secretion system (T4SS) that facilitate the translocation of bacterial effector proteins into eukaryotic target cells [33], [34]. These proteins are now considered conserved T6SS base plate components [13], [14], [35]. C. jejuni TssM contains a Walker A motif (GXXGXGKT/S) in its cytoplasmic N-terminal domain implicated in the ATP hydrolysis energizing the recruitment of Hcp to the TssL-TssM membrane complex [15]. The larger periplasmic part harbors an icmF domain that, in analogy to IcmH and IcmF, may interact with TssL and stabilize the secretion complex [13].

A second group of predicted T6SS components in C. jejuni strain 108 comprises the proteins TssB, TssC, TssE, TssF and TssG (Fig. 2B). TssB (18 kDa) and TssC (55 kDa) are orthologs of the T6SS proteins VipA and VipB that constitute the tubular sheath [10], [11]. C. jejuni TssE (15 kDa) has remote homology to the bacteriophage T4 baseplate protein gp25 and to the V. cholerae ortholog VCA0109 that is essential for Hcp secretion [11]. C. jejuni proteins TssF (66 kDa) and TssG (38 kDa), both predicted to be inner membrane proteins, are homologous to conserved T6SS components of unknown function, although the TssF ortholog in Rhizobium leguminosarum (ImpG) is involved in plant root infection [36]. The C. jejuni TssA (50 kDa) and TagH (35 kDa) proteins resemble T6SS hypothetical proteins. C. jejuni TagH appears to have a forkhead-associated domain (FHA) that may confer phosphoprotein-specific protein-protein interactions and thus may have a regulatory function. The C. jejuni T6SS gene cluster lacks a ClpV-ATPase ortholog implicated in the depolymerization and recycling of the T6SS tubular sheath proteins that may wrap the Hcp inner tube structure [9]–[12].

The protein encoded by the tssI gene located at the C-terminal end of the C. jejuni T6SS gene cluster shows similarity with the Rearrangement hot spot (Rhs) element of the VgrG protein family and with the bacteriophage T4 tail spike protein [7]. VgrG proteins form the T6SS needle tip and can puncture and translocate across eukaryotic membranes [16]. The VgrG-like protein of C. jejuni strain 108 lacks the extended biological effector domain that is often associated with modulation of eukaryotic cell function [16], [37]. The major characteristics of the T6SS gene cluster of C. jejuni strain 108 and its most related orthologs in several other species are summarized in Table 1.

Table 1. Characteristics of C. jejuni T6SS components and their most related orthologs in several other species.

C. jejuni strain 108			V. cholerae O1 biovar eltor	H. hepaticus 51449	C. jejuni RM1221	C. coli RM1228
Name	Size (aa)	COG	Ortholog (accession number)	Ortholog (accession number)	Ortholog (accession number)	Ortholog (accession number)
TssI (vgrG)	841	3501	vgrG VCA0123 (NP_232524)	HH0291 (AAP76839)	CJE1142 (AAW35468) CJE1141 (AAW35467)	CCOA0129 (EAL55897)
TssG	322	3520	vasB VCA0111 (AAF96025)	HH0244 (AAP76841)		CCOA0130 (EAL55898)
TssF	573	3519	vasA VCA0110 (AAF96024)	HH0245 (AAP76842)		CCOA0131 (EAL55899)
TssE (gp25)	130	3518	gp25 VCA0109 (NP_232510)	HH0246 (AAP76843)		CCOA0132 (EAL55900)
TssC (vipB)	484	3517	vipB VCA0108 (NP_232509)	HH0247 (AAP76844)		CCOA0133 (EAL55901)
TssB (vipA)	161	3516	vipA VCA0107 (NP_232508)	HH0248 (AAP76845)		CCOA0134 (EAL55902)
TssA	415	3515	vasJ VCA0119 (AAF96033)			CCOA0135 (EAL55903)
TssJ	148	3521		HH0249 (AAP76846)		CCOA0136 (EAL55904)
TssK	465	3522	vasE VCA0114 (AAF96028)	HH0250 (AAP76847)		CCOA0137 (EAL55905)
TssL (IcmH)	257	3455	vasF VCA0115 (AAF96029)	HH0251 (AAP76848)		CCOA0138 (EAL55906)
TssD (hcp)	171	3157	hcp VCA0017 (NP_232418)	HH0243 (AAP00840)		CCOA0139 (EAL55907)
TssM (IcmF)	1176	3523	vasK VCA0120 (AAF96034)	HH0252 (AAP76849)		CCOA0140 (EAL55908)
TagH	299	3456	vasC VCA0112 (AAF96026)	HH0253 (AAP76850)	CJE1139 (AAW35466)	CCOA0141 (EAL55909)

The T6SS cluster is located on C. jejuni integrative element 3

T6SS gene clusters are usually located on pathogenicity islands or chromosomal regions that show a bias towards bacterial survival or virulence [5]. The G+C content of the C. jejuni T6SS is 26.5%, compared to about 30% for the C. jejuni genome. In C. jejuni strain 108 the T6SS cluster is flanked at the amino- and carboxyterminal ends by orthologs (98% similarity at the amino acid level) of respectively CJE1139 and CJE1141/CJ1142 of strain RM1221. These genes are located on CJIE3, an integrated element present in the genome of several C. jejuni strains including RM1221 [38]. The CJIE3 element of strain RM1221 lacks the T6SS gene cluster but contains CJE1141 and CJE1142 that have Rhs elements. Rhs elements can mediate chromosomal rearrangement or acquisition of new genetic information [39]. A fused homolog of these 2 genes forms the tssL (VgrG) gene at the carboxyterminal end of T6SS of C. jejuni strain 108. This gene organization strongly suggests that the T6SS of C. jejuni 108 is localized within CJIE3 and has inserted between the genes CJE1139 and CJE1141/CJE1142 of strain RM1221. Analysis of C. jejuni strain 108 for the presence of CJIE3 by PCR using a specific primerset [38] confirmed the presence of this element in strain 108. Fig. 2C shows a schematic representation of the insertion of the T6SS locus of C. jejuni strain 108 between genes CJE1139 and CJE1141/CJE1142 in the CJIE3 element of C. jejuni strain RM1221.

Prevalence of C. jejuni T6SS

The localization of C. jejuni T6SS on genetic element CJIE3 in strain 108 and the variable presence of T6SS genes in other C. jejuni genomes led us to determine the T6SS prevalence in C. jejuni. To this end, we analyzed 80 Campylobacter strains for the presence of the hcp gene using PCR. Both human and animal isolates from different regions of the world were analyzed (Table S1). PCR products were obtained for eight C. jejuni and two C. coli strains (Fig. 3). Notably, four of T6SS-positive strains were isolates derived from patients with C. jejuni bacteremia which is a rare event that occurs in <0.2% of intestinal C. jejuni infections [40].

Figure 3. PCR detection of CJIE3 and Hcp in different C. jejuni and C. coli strains.

Only CJIE3-positive strains are shown. C. jejuni strains used are 1 - 108, 2 - 202606, 3 - 209071, 4 - 205223, 5 - NCTC12502 (P3), 6 - RM1221, 7 - C09165, 8 - C019168, 9 - C626, 10 - C631, 11 -C10, 12 - 117, 13 - C356. C. coli strains used are: 14 - Han35, 15 - Han 153. Hcp-positive strains are marked with (+). The size of the PCR products is indicated in base pairs (bp). CJIE3 and hcp were not detected by PCR in the following C. jejuni strains: NCTC11168, NCTC81116, ATCC 33291, ATCC 49301, BAA527, BAA529, C013199, C011338, C017289, C011672, C011300, C013500, C012599, C012446, 5003, D3468, D3141, CCUG10950, D3226, 233.95, 308.95, 21.97, 386.96, 260.94, 41239B, 07479, 127955, 850312, 40707L, GB1, GB5, GB11, GB18, GB23, GB26, GB27, E98623, 480, 209071, 201191, 205224, 207251, 207252, 206470, 206710, 105713, 146719, 209755, 100756, 132960, 210388, 11271, 11279, 81176, A3004, C9, C12, C608, C618, C621, C627; and the C. coli strains: UA417, Han36, 2371, K1102/03, H1.

In order to investigate whether the C. jejuni strains containing the hcp gene also harbored the integrative element CJIE3, DNA from all 80 Campylobacter strains was analyzed by PCR using CJIE3-specific primers [37]. All hcp positive strains scored positive for CJIE3. However, we also identified several CJIE3-positive strains that lacked the hcp gene, like strain RM1221 (Fig. 3).

The organization and genomic integration of the T6SS cluster in the hcp positive C. jejuni strains was further characterized with primers used for the analysis of the T6SS gene cluster in strain 108. This confirmed that the complete T6SS locus was present in all the Hcp-positive C. jejuni strains. The T6SS clusters were flanked at the aminoterminal end by CJE1138 orthologs in 6 out of 8 C. jejuni strains and 1 of 2 C. coli strains. In all strains the carboxyterminal flanking region of T6SS was different than in strain 108 as no PCR products were obtained. Therefore we assume that the complete T6S locus has been acquired by C. jejuni in one step, while integration occurred at different positions of the earlier integrated element CJIE3.

Functional characterization of the C. jejuni T6SS

Evidence that the C. jejuni T6SS is functional was sought by analysis of Hcp secretion. Hereto the hcp gene was expressed in Escherichia coli SE1. A 6×His-tag was fused to the carboxy-terminal end of the protein for purification purposes. Rabbits were immunized with the purified recombinant protein to generate Hcp-specific antibodies. SDS-PAGE and Western blotting confirmed specific reactivity of the antiserum with Hcp (Fig. 4A). Immunoblotting of C. jejuni whole cell lysates and (non-concentrated) culture supernatants using the Hcp-specific antiserum demonstrated Hcp in both fractions (Fig. 4A). Secreted Hcp and cellular Hcp showed a similar apparent molecular mass, suggesting that no additional processing of the protein occurs during secretion. Inactivation of hcp by allelic replacement with a defective copy of the gene yielding strain 108ΔHcp, resulted in loss of immunoreactivity (Fig. 4A).

Figure 4. Western blot demonstrating the presence of Hcp protein.

(A) Cellular (Cj) and culture supernatant (sup) fractions of C. jejuni strain 108 and its Hcp-, TssM- and RpoN-negative derivatives were separated by SDS-PAGE, blotted, and incubated with Hcp-specific antisera. Molecular mass markers are indicated in kilodalton (kDa). (B) Western blot of culture supernatants of the CJIE3-positive C. jejuni strains tested in Fig. 3, demonstrating secretion of Hcp by all T6SS-positive strains. Hcp-secreting strains are marked with (+). The apparent mass of the Hcp protein is indicated in kilodalton (kDa). The strains loaded in lanes 1 to 15 are listed in the legend of Fig. 3.

To gain evidence that Hcp secretion was conferred by the putative T6SS machinery, the C. jejuni tssM gene was inactivated keeping in mind that its ortholog in other species (e.g. VasK in V. cholerae, IcmF in R. leguminosarum) is required for T6SS-dependent Hcp secretion [3]. The mutant was constructed by replacement of the gene with a disrupted copy containing a chloramphenicol resistance cassette, yielding C. jejuni 108ΔTssM. The disrupted gene had inserted in the same orientation as the parent gene as verified by PCR. Western blot analysis of the TssM mutant demonstrated the presence of Hcp in whole bacterial lysates but not in the culture supernatant (Fig. 4A). These results strongly suggest that C. jejuni Hcp is secreted in a T6SS-dependent fashion. Immunoblots of culture supernatants of other hcp-positive C. jejuni strains demonstrated Hcp secretion for all of the tested strains (Fig. 4B).

The presence of large quantities of C. jejuni Hcp in the culture medium suggested constitutive expression of the T6SS genes under standard bacterial growth conditions. In V. cholerae and several other bacterial species, Hcp production requires the alternative transcription factor sigma-54 encoded by the rpoN gene and an enhancer binding protein (e.g. VasH) [3], [6], [41]. Although an ortholog of vasH appears absent from the T6SS locus of C. jejuni 108, we tested the effect of genetic inactivation of C. jejuni rpoN on Hcp expression. This mutant has a defect in flagella assembly and displays a motility deficient phenotype [42]. Immunoblotting of cellular and supernatant fractions of strain 108ΔRpoN revealed unaltered high levels of Hcp for the mutant and parent strain (Fig. 4A). These results suggest that RpoN does not regulate Hcp secretion in C. jejuni.

C. jejuni T6SS causes cytotoxicity toward red blood cells

In search for a biological function of the C. jejuni T6SS we first tested the potential competitive advantage of C. jejuni strain 108 towards other microorganisms. In several bacterial species the presence of T6SS facilitates survival in mixed populations, often through the production of antibacterial toxins that are injected into neighboring bacteria [24], [26], [43], [44]. In our hands, co-culture of C. jejuni strain 108 with E. coli DH5α either in broth or on agar plates for up to 5 days did not reveal a selective growth advantage for the T6SS expressing strain. Similar results were obtained when C. jejuni strain 108 was incubated with the TS6SS-negative C. jejuni strain 81116ΔCPS which has similar growth requirements and growth rate as strain 108.

Although C. jejuni T6SS appeared to lack the extended VgrG protein often associated with cytotoxicity toward host cells, we next tested the effects of C. jejuni strains 108 and 108ΔHcp on eukaryotic cells including Caco-2 intestinal epithelial cells and red blood cells. Confocal laser microscopy on Caco-2 cells infected with strain 108 demonstrated that internalized C. jejuni remained in a CD63-positive endolysosomal compartment for up to 24 h [45], suggesting that T6SS apparatus did not cause lysis and bacterial escape from the intracellular vacuole. The effect of the T6SS on erythrocytes was assessed by measurement of hemolytic activity after 6 h of incubation of the red blood cells with C. jejuni. This showed that C. jejuni 108 caused strong hemolysis compared to mutant strain 108ΔHcp (Fig. 5A). Complementation of the hcp mutant by the introduction of plasmid pMA1-hcp carrying an intact copy of the hcp gene restored the strong T6SS-associated cytotoxicity (Fig. 5A ). We also tested the tssM mutant for hemolytic activity. This mutant failed to induce Hcp-induced hemolysis consistent with the observed essential function of the TssM protein in Hcp secretion (Fig. 5A). Western blotting confirmed that the complementation of the hcp mutant and inactivation of tssM resulted the expected changes in Hcp secretion (Fig. 5B). Isolated culture supernatant of strain 108 lacked hemolytic activity, suggesting that the T6SS phenotype involved contact-dependent hemolysis. It is important to note that the T6SS-induced hemolysis was observed for C. jejuni grown on agar plates for 7 days and then in HI broth for 16 h (7 p/16 h)(Fig. 5C). C. jejuni grown on agar plates for 3 days followed by growth in HI broth for 8 h (3 p/8 h) failed to consistently induce substantial hemolysis (Fig. 5C).

Figure 5. Hemolysis assay depicting the T6SS-mediated hemolytic activity of C.

jejuni. (A) C. jejuni strain 108, its hcp-negative derivative 108ΔHcp, the complemented mutant strain 108ΔHcp/phcp, and the parent strain carrying phcp grown for 7-days on saponin plates and then for 16 hours in HI broth (7 p-16 h) were incubated (6 h) with red blood cells before hemolysis was determined. (B) Western blot confirming the successful restoration of Hcp secretion in 108ΔHcp after introduction of the complementation plasmid phcp. (C) Effect of the age of C. jejuni cultures in T6SS-induced hemolysis. Strain 108 and 108ΔHcp grown either on saponin plates for 3 days and then in HI broth for 8 h (3 p/8 h), or on saponin plates for 7 days and then in HI broth for 16 h (7 p/16 h) were incubated with red blood cells for 6 h. Then hemolysis was determined by measuring absorbance at 420 nm. Values are the mean ± SEM of at least three experiments.

Capsule impairs T6SS function

In an attempt to understand the apparent bacterial growth-related variation in T6SS phenotype, we hypothesized that perhaps the C. jejuni surface capsule polysaccharide (CPS) interfered with the contact-dependent hemolysis. To test this hypothesis we first analyzed the CPS of C. jejuni 108 at different age of culture using Alcian blue staining. This revealed variable intensity of capsule staining with highest levels of capsule expression for C. jejuni grown on agar plates for 3 days and then in HI broth for 16 h (3 p/16 h) (Fig. 6A). At earlier (3 p/8 h) and later (7 p/16 h) time points, CPS levels were much lower (Fig. 6A). This seemed to exclude variable CPS expression as a cause of the observed variation in T6SS-mediated hemolysis at these time points (Fig. 5C).

Figure 6. Effect of capsule expression on T6SS-mediated hemolysis.

(A) SDS-PAGE of C. jejuni strain 108 and its capsule-negative mutant 108ΔCPS stained for the presence of capsule polysaccharide with Alcian blue. Capsule expression was compared for equal amounts of C. jejuni grown on saponin plates for three (3 p) or seven (7 p) days and then in HI broth for the indicated times (8 h or 16 h). Molecular mass markers are indicated in kilodalton (kDa). (B) T6SS-mediated hemolysis (6 h) for C. jejuni strain 108 and 108ΔHcp in a capsule-negative background (ΔCPS). Hemolysis was determined by measuring absorbance at 420 nm. Values are the mean ± SEM of at least three experiments. (C) Hemolysis assay depicting the hemolytic activity (6 h) of C. jejuni strain 108 (WT), the capsule mutant 108ΔCPS, the double mutant 108ΔCPS/ΔHcp, and the Hcp secretion-defective strain 108ΔTssm, and of the T6SS-negative strain 81116 (WT) and its capsule mutant 81116ΔCPS. Strains used were grown for 3 days on saponin plates and then for 16 h in HI broth (3 p/16 h). The hemolysis results depicted in the left panel were quantified by measuring absorbance at 420 nm (right panel). (D) Effect of T6SS on J774A.1 macrophages. Macrophages were incubated with C. jejuni strain 108, 108ΔHcp, 108ΔCPS, 108ΔCPS/ΔHcp or S. Typhimurium SL1344. After 10 h of incubation, total cellular and released lactate dehydrogenase (LDH) were measured as indicator of cytotoxicity. Values are the mean ± SEM of at three independent experiments performed in triplicates. (E) Real-time RT-PCR results showing hcp transcript levels for C. jejuni strain 108 and 108ΔCPS at different age (3 p/8 h and 3 p/16 h). Note the strong relative increase in hcp transcript level in late exponential growth phase. Data are representative of three independent experiments with two independent preparations of RNA.

To definitively exclude the capsule as an inhibitory factor of T6SS function, we tested the capsule-deficient strain C. jejuni 108ΔCPS for hemolytic activity. The mutant was constructed by allelic exchange of the kpsM gene with a disrupted copy of this gene. Unexpectedly, C. jejuni 108ΔCPS displayed strong cytotoxicity at all tested time points except during early exponential growth phase (3 d/8 h) (Fig. 6B). The cytotoxic effect of the CPS mutant was abolished after additional inactivation of hcp or tssM (Fig. 6C), indicating that the hemolysis required a functional T6SS. Genetic inactivation of kspM in C. jejuni 81116, which lacks the T6SS gene cluster, did not result in enhanced hemolysis (Fig. 6C). Together, these results demonstrate that C. jejuni T6SS confers a cytotoxic phenotype toward red blood cells but that this function requires downregulation of the polysaccharide capsule. Notably, similar experiments with strains 108, 108ΔCPS, 108ΔHcp and 108ΔCPS/ΔHcp and J774A.1 macrophages caused minimal cell damage (i.e. LDH release), irrespective the presence of a functional T6SS (Fig. 6D).

The issue that remained to be resolved was why the 3 d/8 h C. jejuni culture fails to show the T6SS phenotype even in the capsule-negative background. To address the point, we compared relative transcript levels of hcp in 3 p/8 h and 3 p/16 h cultures for C. jejuni strains 108 and 108ΔCPS. Real-time PCR analysis showed 5–10 fold more hcp transcript for the 3 p/16 cultures compared to 3 p/8 h bacteria both for the parent and cps mutant strain (Fig. 6E). These results indicate that C. jejuni hcp mRNA levels vary between growth conditions and suggest that in the early logarithmic phase C. jejuni Hcp levels may be insufficiently expressed to induce the hemolytic phenotype.

Discussion

Type VI secretion systems are bacterial nano-injection machines that transport macromolecules into neighboring prokaryotic or eukaryotic cells. The toxic effector molecules serve to outcompete other bacterial species [24], [43] or to alter host cells during pathogenesis [36], [46; for review see] [47]. Here we report the existence and function of a T6SS pathogenicity island in the principal bacterial food-borne pathogen C. jejuni. The T6SS gene cluster is present in about 10% of the C. jejuni isolates and has inserted into C. jejuni integrated element 3 (CJIE3). The function is evidenced by the secretion of the hallmark hemolysin co-regulated protein Hcp. C. jejuni T6SS is special among the T6SS family because it confers contact-dependent cytotoxicity toward red blood cells and because its function requires down-regulation of the polysaccharide capsule. The capsule controlled cytotoxicity of C. jejuni T6SS adds a new element to the growing repertoire of T6SS regulation mechanisms and phenotypes.

The T6SS cluster of C. jejuni consists of 13 genes that most resemble the T6SS genes of C. coli and H. hepaticus both with regard to gene organization and content (Fig. 2). In addition to the hallmark Hcp and VgrG-like proteins, predicted C. jejuni T6SS proteins include the TssJ-M proteins encoding base plate components of the secretion apparatus [13], and TsB (VipA), TssC (VipB) and TssE (gp25 protein) that form structures that resemble the evolutionary related bacteriophage tail sheath and baseplate proteins [4], [5]. The C. jejuni T6SS locus lacks the frequently found TssH gene (COG0542) encoding a ClpV ATPase implicated in the recycling of the TssB/TssC tubular sheath [9], [11]. Although important for sheath contraction and recycling, ClpV is not essential for T6SS function in V. cholerae [48]. Alternatively, it is possible that a related member of the ClpB family of ATPases encoded from elsewhere on the C. jejuni genome partakes in T6SS function, although analysis of the (incomplete) genome of strain 108 has thus far failed to detect a ClpV homologue in strain 108 (unpublished results).

The C. jejuni T6SS genes are only present in isolates that carry the integrative element CJIE3 (integrated into the 3′ end of an arginyl-tRNA). This element is likely plasmid derived and appears to consist of modular regions of unknown function that differ between CJIE3-positive strains [38]. The prevalence of CJIE3 among our 80 tested C. jejuni isolates and those used in the Parker study, is approximately 18%. Yet, only approximately 10% of the isolates contained the T6SS locus. Based on the difference in T6SS flanking regions in our isolates, we assume that the T6SS genes have been acquired en bloc and inserted at different positions into the previously acquired CJIE3.

The function of C. jejuni T6SS as a secretion apparatus is evident from the accumulation of Hcp in the culture medium and the defective Hcp secretion (but intact production) in the constructed tssM-defective strain (Fig. 4A). It is noteworthy that Hcp secretion was apparent under most routine laboratory growth conditions. In other bacterial species T6SS function often appears in response to distinct environmental cues. Although the signals triggering the expression of T6SS genes are still unknown, environmental conditions like temperature, pH, iron or the presence of host cells may influence their induction [49]. Involved regulatory systems include the sensor kinase RetS in Pseudomonas aeruginosa [50] and the Burkholderia mallei VirAG two-component system and AraC-type activator BMAA1517 [51]. Expression of T6SS gene clusters in Vibrio cholerae, Aeromonas hydrophyla and Pseudomonas syringae is regulated by sigma-54 and cognate enhancer binding proteins (e.g. VasH) [48]. We show that sigma-54 is not required for C. jejuni T6SS protein secretion (Fig. 4A). The molecular basis of the relative poor Hcp expression in the early exponential growth phase remains to be determined. A plausible alternative explanation for the limited gene regulation of C. jejuni T6SS may be this pathogen has evolved the described alternative strategy of capsule-sensitive T6SS function.

Our results indicate that C. jejuni T6SS causes contact-dependent lysis of red blood cells. Bacterial competition assays with T6SS-negative C. jejuni and E. coli yielded no conclusive T6SS phenotype under the conditions employed. Furthermore, incubation of C. jejuni 108ΔCPS with J774A.1 macrophages did not result in cytotoxicity (Fig. 6D) and the presence of T6SS did not seem to enable the intracellular C. jejuni to escape from the endolysosomal compartment [45]. Several lines of evidence indicate that the observed hemolysis was caused by T6SS activity: (i) Hemolysis was strongly reduced in the hcp and tssM mutants, (ii) complementation of the hcp mutant with an intact copy of the gene restored the phenotype, (iii) hemolysis was minimal for strain 81116 that lacks the T6SS gene cluster. The low level of hemolysis measured after prolonged incubation with the mutant strains (Fig. 6) may be attributed to the presence of membrane bound hemolysins, such as phospholipase A [52]. The strong T6SS-mediated hemolytic activity may benefit C. jejuni by increasing the availability of nutrient sources such as iron and nicotinamide adenine dinucleotide (NAD) that are abundantly present in erythrocytes.

A key feature in establishing the C. jejuni T6SS phenotype was the explanation of the initially highly variable results by changes in the level of capsule expression. The use of constructed capsule- and Hcp-negative mutant strains unequivocally demonstrate C. jejuni polysaccharide capsule as a key determinant controlling T6SS-induced hemolysis. To our knowledge capsule expression has not previously been implicated as a factor influencing the activity of T6SS. We propose that the polysaccharide capsule inhibits T6SS function by acting as a steric barrier that prevents the T6SS needle structure to puncture the host cells. In addition, needle length may be of importance as suggested by the poor hemolytic activity of capsule-negative strains at early growth phase when C. jejuni hcp transcript levels were much lower (Fig. 6). Thus, capsule thickness in conjunction with needle length may determine T6SS function in C. jejuni, reminiscent of the control of the function of the type III injectisome by needle length [53] and the extent of LPS glucosylation in Shigella flexneri [54]. The factors that regulate capsule expression in C. jejuni are not well defined [27], although recent studies indicate that downregulation of capsule does occur upon contact with host cells [55], [56]. In addition, at least in some C. jejuni strains capsule biosynthesis is subject to phase variation [57]. This event has not been demonstrated to occur in strain 108, but, when present, may result in a subset of the bacterial population with a functional T6SS phenotype. This scenario may explain the basal level of hemolysis observed for the wildtype C. jejuni strain 108.

An intriguing issue is as to why a subset of C. jejuni strains has acquired and maintains a seemingly genetically stable and functional T6SS pathogenicity island. Its relatively low prevalence (10%) and absence in many disease isolates indicate that the T6SS is not an essential virulence factor in intestinal infections but rather may be advantageous for the bacterium in a distinct niche. We did note that four out of the eight TSS6-positive C. jejuni isolates identified in this study were derived from human patients with Campylobacter bacteremia. This seems disproportionally high considering that C. jejuni bacteremia occurs in <0.2% of intestinal infections, often in immunocompromised patients [40]. We tested C. jejuni growth in human blood from healthy donors. This resulted resulted in rapid bacterial killing irrespective the presence of T6SS, indicating that in healthy donors bacterial killing mechanisms dominate over the possible growth advantage of T6SS-positive strains due to e.g. the release of nutrients from red blood cells. Similar assays in horse blood revealed no differences in bacterial growth/survival between strain 108 and the T6SS mutant (Fig. S1). The T6SS-positive C. jejuni blood isolates identified in the present study were all derived from patients with hypogammaglobulinemia, which may limit rapid bacterial killing. Yet, considering the low number of available blood isolates, we feel it too early to conclude that T6SS-mediated hemolysis contributes to the development of C. jejuni bacteremia.

The presence of a functional T6SS in C. jejuni has recently been confirmed in a parallel study using strain 43431 [58]. The T6SS gene cluster in this strain also lacks a ClpV homologue. Inactivation of T6SS function in this strain resulted in increased resistance to high concentrations of bile salts, possibly by preventing entry of bile salt through the opened secretion channel [58]. The mutant also showed approximately 50% reduced bacterial adhesion and invasion of host cells. Whether the observations with this strain also varied with the presence of the polysaccharide capsule was not investigated.

Overall, our study provides the first evidence that (i) ∼10% of C. jejuni isolates carry a complete T6SS gene cluster in the integrative element CJIE3, (ii) the T6SS system is functional, (iii) C. jejuni T6SS confers cytotoxicity toward red blood cells, and (iv) the T6SS phenotype requires down regulation of the polysaccharide capsule. To our knowledge, T6SS-mediated hemolysis and an effect of capsule on T6SS function has never been reported for other bacterial species. C. jejuni T6SS represents a novel direction in the evolution of T6SS, expands the existing repertoire of T6SS-mediated effects on eukaryotic cells, and may contribute to systemic C. jejuni infection.

Materials and Methods

Bacterial strains and growth conditions

The bacterial strains used in this study are listed in Supporting Information (Table S1). Campylobacter was grown at 37°C under micro-aerobic conditions (5% O₂, 10% CO₂, 85% N₂) either on Saponin agar plates containing agar base II medium (Oxoid Ltd., Basingstoke, UK) with 5% saponin lysed horse blood, or in 5 ml of Heart Infusion broth (HI) (Oxoid) in 25 cm² tissue culture flasks at 160 rpm. Escherichia coli were grown in Luria-Bertani medium at 37°C. When appropriate, growth media were supplemented with ampicillin (100 µg/ml), kanamycin (20 µg/ml), or chloramphenicol (20 µg/ml).

Genetic analysis of T6SS locus

The nucleotide sequence of the primers used for cloning and sequencing the T6SS locus are listed in Supporting Information (Table S2). DNA fragments encoding T6SS genes were PCR amplified by primer walking using 500 ng of isolated C. jejuni 108 genomic DNA as template, 2.5 U of Super Taq+ polymerase (HT Biotechnology Ltd. UK), 50 pmol of each primer, and 0.1 mM of dNTPs in a final volume of 50 µl of 10 mM of Tris-HCl, 1.5 mM of MgCl₂ and 50 mM KCl. Standard PCR conditions were heating for 2 min at 95°C, followed by 35 cycles of 15 s at 95°C, 15 s at 52°C, and 5 min at 72°C in a BioRad iCycler. Amplified products were subjected to agarose gel electrophoresis, purified with the Qiaex II gel extraction kit (Qiagen), and cloned using pGEM-Teasy (Promega) or PJet (Fermentas) in E. coli DH5α. Primers T7 and Sp6 were used to determine the nucleotide sequences of the pGEM-Teasy inserts. The PJet1.2 forward and reverse primers were used to sequence the pJet1.2 inserts (Baseclear, Leiden, The Netherlands). Sequences were analyzed and aligned using the DNASTAR software package (Lasergene). The complete sequence of the T6SS gene cluster of C. jejuni strain 108 is deposited at GenBank (Accession number: JX436460).

Construction of C. jejuni mutants

Primers used for construction of mutants are listed in Supporting Information Table S3. The hcp and tssM gene with their flanking sequences of strain 108 were amplified by PCR as described above. PCR products were cloned into pGEM-T easy. Inverse PCR on pGEMhcp was used to delete 166 bp of hcp and to introduce a BamHI restriction site. Plasmid pGEMtssM was cut with bglII. The chloramphenicol resistance gene (Cm) from pAV35 was ligated into the created BamHI site in hcp and into the BglII site in tssM, yielding pGEMhcp::cm and pGEMtssM::cm, respectively. Knockout plasmids carrying the Cm gene in the same orientation as the hcp and tssM genes were used to transform C. jejuni 108 by electroporation. Mutants were selected on saponin agar plates containing 20 µg/ml of chloramphenicol. Disruption of the genes was verified by PCR.

For construction of C. jejuni 81116ΔCPS the kpsM gene with flanking sequences was amplified with primers listed in Table S3 and cloned into pGEM-T easy. A deletion of 300 bp was made using inverse PCR thereby creating a unique BglII restriction site. The 2,000 bp tetracycline resistance gene from pTetO was inserted into this BglII site, yielding pGEM-T easy kpsM::tet. Natural transformation was used to introduce the knockout plasmid into C. jejuni 81116. Mutants were selected on saponin agar plates containing 15 µg/ml of tetracycline. BglII digestion was used to replace the tetO gene in the pGEM-T easy kpsM::tet construct with the Cm gene from pAV35. The resulting plasmid pGEMkpsM::cm was introduced in C. jejuni 108 via electroporation, yielding strain 108ΔCPS. Chloramphenicol resistant transformants were selected and gene disruption was confirmed by PCR.

Complementation of the hcp mutant

The hcp gene including its ribosomal binding site was PCR amplified from strain C. jejuni 108 using primers 276 and 277. After digestion with XhoI and XbaI, the resulting 531 bp fragment was cloned into the pMA1 vector behind the C. jejuni metK promoter [59], yielding pMA1hcp. The plasmid was introduced by electroporation into C. jejuni 108 wild type and the hcp mutant, and kanamycin resistant transformants were selected.

Cloning, expression, and purification of recombinant Hcp

The hcp gene was PCR amplified from C. jejuni 108 genomic DNA with primers 210 and 211 and fused to a C-terminal 6× histidine tag using the XbaI–XhoI sites of pSCodon1 (Delphi genetics SA). Selection of pSCodon1hcp was performed in E. coli CYS21, while E. coli SE1 was used to express the Hcp protein (Staby Codon T7 manual, Delphi genetics SA). An overnight culture of E. coli pSCodon1hcp in Staby Switch auto-inducible medium (Eurogentec, Belgium) was used to isolate His-tagged Hcp from the soluble cytosolic fraction. Recombinant protein was purified under native conditions using Ni-NTA agarose and 250 mM of imidazole in the elution buffer as described in the manual (Qiagen). Eluted fractions were analyzed by SDS-PAGE. Hcp-positive fractions were pooled and dialyzed for 20 h against 3 liter of 50 mM of Tris-HCl buffer (pH 7.6) containing 200 mM of KCl, 10 mM of MgCl₂, 0.1 mM of EDTA, 10% glycerol, and then against the same buffer containing 50% glycerol.

Hcp antibody production

Two New Zealand White rabbits (SPF) were immunized four times (Days 0, 14, 28 and 56) with 100 µg of purified Hcp protein using the classical anti-protein protocol (Eurogentec, Belgium). Serum aliquots were collected (Days 0, 38, 66 and 87) and stored at −20°C. Dilutions of sera were tested by Western blot analysis for Hcp reactivity. All immunizations and handling of animals were performed by Eurogentec, Belgium.

Western blot analysis

For protein detection, aliquots of bacterial cultures (16 h, HI broth) were pelleted (4,000× g, 15 min) and dissolved in the same volume of Laemmli electrophoresis solution containing 30 mM of Tris-HCl (pH 6.8), 4% SDS, 0.025% bromophenol blue and 20% glycerol. The bacterial supernatant was subjected to high speed centrifugation (18,500× g, 15 min) to remove supramolecular structures and mixed at a 3∶1 (v/v) ratio with 3×-concentrated Laemmli solution. After boiling (10 min), the equivalent of 10 µl of bacterial culture was loaded onto a 12% SDS-polyacrylamide gel. Proteins were transferred to PVDF membranes (Immobilon-P, Millipore). After blocking (5% skim milk powder (Elk, Campina), 0.1% Tween 20), Hcp was detected with rabbit anti-Hcp antiserum (1/500 in PBS, 2% skim milk, 0.1% Tween 20) in combination with horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology) and Super signal west pico chemiluminescent substrate (Pierce).

Two-dimensional gel electrophoresis and mass spectrometry

Two-dimensional gel electrophoresis was generously carried out by Dr. Bas van Balkom as previously described [60], except that precast immobilized nonlinear pH (pH 3 to 10) gradient strips (Amersham Biosciences) were used. In-gel tryptic digestion and mass spectrometry analysis were performed as described [60].

Detection of polysaccharide capsule

For capsule detection, bacteria (2×10⁹) were suspended in 100 µl of Laemmli buffer. Next, 30 µl of 20 mg/ml proteinase K in water was added and the mixture was incubated at 55°C for 2 h. Capsular polysaccharides were separated on a 12% SDS-PAGE gel. Gels were washed twice in water and stained (1 h) with filtered 0.5% Acian Blue 8GX (Sigma) in 2% acetic acid/40% methanol. Gels were destained in 2% acetic acid/40% methanol until bands became visible [60]. SDS-PAGE and protein staining of non-digested aliquots of the samples confirmed equal loading of bacteria.

Cytotoxicity assays

C. jejuni grown on saponin agar plates for 3 or 7 days were transferred to HI broth (OD₅₅₀: 0.05) in 25 cm² flask and shaken (160 rpm) for 8 h or 16 h at 37°C under microaerophillic conditions. Bacterial pellets from solid and broth media were suspended in PBS to OD₅₅₀ of 1. One ml of this bacterial suspension was then mixed with 0.25 ml of a 5% (v/v) horse erythrocyte suspension (Biotrading) kept in PBS with 0.4 mM of CaCl₂ in a 1.5 ml plastic tube with a perforated cap. After incubation (37°C, 6 h, microaerophilic conditions), the tubes were mixed and centrifuged (1,000× g, 5 min). The OD₄₂₀ of the supernatants was then measured as indicator of the degree of hemolysis. Negative (with PBS without bacteria) and positive (with added water instead of bacterial suspension) controls were included in all assays. Cytotoxicity was scored as percentage of cell lysis of the positive control. Data are expressed as the mean ± SEM of at least three independent experiments.

Cytotoxicity toward macrophages was determined using J774A.1 macrophages (ATCC) grown for 24 h in a 24-well plate in DMEM+10% FCS at 37°C in a 10% CO₂ atmosphere. Prior the use the medium was replaced by 1 ml of fresh DMEM (without FCS). C. jejuni strains 108, 108ΔHcp, 108ΔCPS, 108ΔCPS/ΔHcp and (as control) Salmonella Typhimurium strain SL1344 were grown in HI broth, collected by centrifugation (10 min, 3,000× g), and added to the macrophages at a bacteria to host cell ratio of 20. After 2 h of incubation (37°C, 5% CO₂), the extracellular Salmonella were removed and 1 ml of DMEM+50 µg/ml gentamicin was added. The cells were incubated for an additional 10 h before total cellular LDH and LDH release from the cells was determined with the Cytotoxicity Detection Kit according to the protocol of the manufacturer (Roche). The supernatant or the lysed cells stained with the kit was analyzed on the FLUOstar omega (BMG Labtech) at 492 nM and 690 nM for wavelength correction. Cytotoxicity was determined by calculating the percentage of LDH released after background subtraction. C. jejuni had no effect on the LDH itself or the assay. Presented results are from three individual assays performed in triplicate. Data were analyzed using Graphpad Prism software.

Survival of C. jejuni in blood

C. jejuni strain 108, 108ΔCPS and 108ΔCPS/ΔHcp grown in HI broth (16 h, 37°C) were collected by centrifugation (15 min, 4000× g) and suspended in 50 µl of HI broth. Bacteria (10⁹ CFU) were, added to 3 ml of heparinized human or defibrinated horse blood in 35 mm petri dishes and incubated at 37°C under micro-aerobic conditions. After 0, 6, 24 and 48 h, 10 µl aliquots were taken, serially diluted in PBS, and plated onto saponin agar plates. Bacterial survival was determined by counting the number of colony forming units after 48 h of incubation at 37°C under micro-aerobic conditions.

Real-time RT-PCR

Total bacterial RNA was extracted from C. jejuni strain 108 and 108ΔCPS grown in 25 ml of HI Broth for 8 or 16 h at 37°C under micro-aerobic conditions, using the RNA-Bee kit (Tel-Test, Inc) according to the manufacturer's specifications. Isolated RNA was treated with 1 µg of DNase (Fermentas) per µg of RNA for 30 min at 37°C, after which the DNase was inactivated by heating at 65°C for 10 min in the presence of EDTA (2.5 mM final concentration). Real time RT-PCR analysis was performed using the Brilliant III Ultrafast SYBR Green QRT-PCR master mix (Agilent, Stratagene Inc). The PCR mixture (20 µl) contained 40 ng of DNase treated RNA, 20 pmol of the Hcp gene specific primers hcp-RT forw (5′-ACCCGATTTATATCTATTGCCAAT-3′) and hcp-RT rev (5′-GAAGGTTCCACACAAGGTTTGAT-3′), 10 µl of 2× SYBR green mix, 0.2 µl of 100 mM of DTT and 1 µl of RT/RNAse block. The reverse transcriptase cycle was 50°C for 10 min, followed by a PCR initial activation step of 95°C for 3 min. The mixtures were then amplified in 45 cycles of 95°C for 5 sec and 60°C for 10 sec in a Light Cycler 480 (Roche). Total hcp mRNA in each sample was normalized against the internal controls gyrA and rpoA. Three independent experiments with two independent preparations of RNA were analyzed by real-time RT-PCR.

Supporting Information

Figure S1

Growth of C. jejuni strain 108, 108ΔCPS and 108ΔCPS/ΔHcp in blood.

(TIF)

Table S1

Strains and plasmids used in this study.

(DOC)

Table S2

Primers used for cloning and sequencing of the T6SS locus of C. jejuni strain 108.

(DOC)

Table S3

Primers used for construction of mutants and expression vectors.

(DOC)

Funding Statement

The work was supported by the the Danish Agency for Science, Technology and Innovation (CamVac grant number: 09-067131) and the European Union (CamCon grant number: 244547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.